Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cardiovascular Research

• Publication date

  2005-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CARDIORES.2005.02.004PMID 15914110
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of Oxfenicine on cardiac carbohydrate metabolism in intact dogs

  2005cited by this paper
• Peroxisome Proliferator-Activated Receptors and Atherogenesis: Regulators of Gene Expression in Vascular Cells Nuclear Receptor Signaling in the Control of Cholesterol Homeostasis: Have the Orphans Found a Home? Nuclear Receptor Signaling and Cardiac Energetics

  2004cited by this paper
• Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure.

  2004cited by this paper
• Nuclear receptor signaling and cardiac energetics.

  2004cited by this paper
• Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation.

  2004cited by this paper
• Preservation of NO production by statins in the treatment of heart failure.

  2003cited by this paper
• Myeloperoxidase and Plasminogen Activator Inhibitor 1 Play a Central Role in Ventricular Remodeling after Myocardial Infarction

  2003cited by this paper
• Matrix metalloproteinases: regulation and dysregulation in the failing heart.

  2002cited by this paper
• Energy Metabolism in the Normal and Failing Heart: Potential for Therapeutic Interventions

  2002cited by this paper
• The Use of Partial Fatty Acid Oxidation Inhibitors for Metabolic Therapy of Angina Pectoris and Heart Failure

  2002influential reference
• Lipid peroxidation-derived aldehydes and oxidative stress in the failing heart: role of aldose reductase.

  2002cited by this paper
• Impaired Myocardial Fatty Acid Oxidation and Reduced Protein Expression of Retinoid X Receptor-&agr; in Pacing-Induced Heart Failure

  2002cited by this paper
• Metabolic Gene Expression in Fetal and Failing Human Heart

  2001cited by this paper
• Reactivation of Peroxisome Proliferator-activated Receptor α Is Associated with Contractile Dysfunction in Hypertrophied Rat Heart*

  2001cited by this paper
• Etomoxir: a new approach to treatment of chronic heart failure.

  2000cited by this paper
• Sarcoplasmic reticulum function and carnitine palmitoyltransferase‐1 inhibition during progression of heart failure

  2000cited by this paper
• Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1.

  1999cited by this paper
• Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function.

  1998cited by this paper
• Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog.

  1998influential reference
• Fatty acid oxidation enzyme gene expression is downregulated in the failing heart.

  1996cited by this paper
• Inhibition of fatty acid metabolism alters myocardial high-energy phosphates in vivo.

  1994cited by this paper
• Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

  1991cited by this paper
• Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure.

  1986cited by this paper
• Cardiac hypertrophy in the dog and rat induced by oxfenicine, an agent which modifies muscle metabolism.

  1984cited by this paper
• Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements

  1978cited by this paper

• Unrestrained fatty acid oxidation triggers heart failure in mice via cardiolipin loss and mitochondrial dysfunction

  2026cites this paper
• DHA, a potentially therapeutic lipid for myocardial infarction

  2025cites this paper
• Metabolic Disturbances Involved in Cardiovascular Diseases: The Role of Mitochondrial Dysfunction, Altered Bioenergetics and Oxidative Stress

  2025cites this paper
• CPT1A exacerbates trastuzumab-induced cardiotoxicity via promotion of mitochondrial dysfunction.

  2025cites this paper
• Prophylactic administration of kanli granule maintains fatty acid oxidation in the myocardium to prevent heart failure via activating AMPK/PPARα/CPT1A pathway: A network pharmacology-based study.

  2025cites this paper
• AAV-mediated overexpression of CPT1B protects from cardiac hypertrophy and heart failure in a murine pressure overload model

  2025cites this paper
• From exosomes to mitochondria and myocardial infarction: molecular insight and therapeutic challenge.

  2024cites this paper
• Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation

  2024cites this paper
• Future scope and challenges for congestive heart failure: Moving towards development of pharmacotherapy.

  2022cites this paper
• Metabolomic and transcriptomic studies of improvements in myocardial infarction due to Pycr1 deletion

  2022cites this paper
• Short-Chain Carbon Sources

  2022cites this paper
• Legumes as Functional Food for Cardiovascular Disease

  2021cites this paper
• Cardiometabolism as an Interlocking Puzzle between the Healthy and Diseased Heart: New Frontiers in Therapeutic Applications

  2021cites this paper
• Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?

  2020cites this paper
• Increasing mitochondrial ATP synthesis with butyrate normalizes ADP and contractile function in metabolic heart disease

  2020cites this paper
• Cardiac foetal reprogramming: a tool to exploit novel treatment targets for the failing heart

  2020cites this paper
• Cerebral venous congestion promotes blood-brain barrier disruption and neuroinflammation, impairing cognitive function in mice

  2019cites this paper
• Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies

  2019cites this paper
• Carnitine Inborn Errors of Metabolism

  2019cites this paper
• Metabolic Coupling as a Therapeutic Strategy for Heart Failure

  2019cites this paper
• Perioperative Heart-Brain Axis Protection in Obese Surgical Patients: the Nutrigenomic Approach.

  2018cites this paper
• Pyruvate dehydrogenase activation precedes the down-regulation of fatty acid oxidation in monocrotaline-induced myocardial toxicity in mice

  2018cites this paper
• The effects of ginsenoside Rb1 on fatty acid β-oxidation, mediated by AMPK, in the failing heart

  2018cites this paper
• Cardiac metabolism — A promising therapeutic target for heart failure

  2017cites this paper
• Identification and Characterization of a Cardiomyopathy Syndrome Resulting from Loss of the Melanocortin 4 Receptor

  2017cites this paper
• Energetic Metabolic Roles in Pulmonary Arterial Hypertension and Right Ventricular Remodeling.

  2016cites this paper
• Cardiac Metabolism and Energetic Control

  2016cites this paper
• Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion.

  2016cites this paper
• Cardiomyocytes – Active Players in Cardiac Disease

  2016cites this paper
• The Role of Nitric Oxide and the Regulation of Cardiac Metabolism

  2016cites this paper
• Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update

  2016cites this paper
• Cardiac‐specific down‐regulation of carnitine palmitoyltransferase‐1b (CPT‐1b) prevents cardiac remodeling in obese mice

  2016cites this paper
• Metabolic modulation by medium chain triglycerides prevents cardiac remodeling in Spontaneously Hypertensive Rat

  2015cites this paper
• An experimental approach to study the function of mitochondria in cardiomyopathy

  2015cites this paper
• Metabolic efficiency in remodeled failing hearts

  2015cites this paper
• ventricular tachypacing in dogs contributes to cardiac decompensation during chronic Altered expression of a limited number of genes

  2015cites this paper
• Testing metabolic and pharmacological agents for recovery following de novo acute heart failure in an isolated rat heart model

  2014cites this paper
• Heart Failure and Loss of Metabolic Control

  2014cites this paper
• Failing mouse hearts utilize energy inefficiently and benefit from improved coupling of glycolysis and glucose oxidation.

  2014cites this paper
• Chemical-genetic induction of Malonyl-CoA decarboxylase in skeletal muscle

  2014cites this paper
• Cardiac Energetic Impairment in Heart Disease and the Potential Role of Metabolic Modulators: A Review for Clinicians

  2014cites this paper
• Metabolic impairment in heart failure: the myocardial and systemic perspective.

  2014cites this paper
• Inhibition of Fatty Acid Oxidation to Treat Heart Failure in Patients

  2014cites this paper
• Targeting Transcriptional Control of Fatty Acid Oxidation to Treat Heart Disease

  2014cites this paper
• Effect of Inhibiting Malonyl-CoA Decarboxylase on Cardiac Remodeling after Myocardial Infarction in Rats

  2014cites this paper
• Fuel Metabolism Plasticity in Pathological Cardiac Hypertrophy and Failure

  2014cites this paper
• Myocardial oxidative stress in patients with active infective endocarditis.

  2013cites this paper
• From cell phenotype to epigenetic mechanisms: new insights into regenerating myocardium.

  2013cites this paper
• Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes.

  2013cites this paper
• Cardiac metabolism in hypertrophy and heart failure: implications for therapy

  2013cites this paper
• Carnitine Palmitoyltransferase-1b Deficiency Aggravates Pressure Overload–Induced Cardiac Hypertrophy Caused by Lipotoxicity

  2012cites this paper
• Mechanisms involved in the differential reduction of omega-3 and omega-6 highly unsaturated fatty acids by structural heart disease resulting in "HUFA deficiency".

  2012cites this paper
• The study of myocardial metabolism and its role in the pathophysiology of early diabetic cardiomyopathy

  2012cites this paper
• Effect of Chronic CPT-1 Inhibition on Myocardial Ischemia-Reperfusion Injury (I/R) in a Model of Diet-Induced Obesity

  2012cites this paper
• Mitochondria as a Drug Target in Ischemic Heart Disease and Cardiomyopathy

  2012cites this paper
• Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury.

  2012cites this paper
• Reducing the Burden of Ischemia Reperfusion

  2012cites this paper
• Carnitine Palmitoyltransferase-1 b ( CPT 1 b ) Deficiency Aggravates Pressure-Overload-Induced Cardiac Hypertrophy due to Lipotoxicity

  2012cites this paper
• Dietary fat and heart failure: moving from lipotoxicity to lipoprotection.

  2012cites this paper
• Differential effects of high-fat diet on myocardial lipid metabolism in failing and nonfailing hearts with angiotensin II-mediated cardiac remodeling in mice.

  2012cites this paper
• Metabolic therapy for heart failure including diastolic heart failure

  2012cites this paper
• Hyperpolarized Magnetic Resonance: A Novel Technique for the In Vivo Assessment of Cardiovascular Disease

  2011cites this paper
• Impaired Mitochondrial Biogenesis Precedes Heart Failure in Right Ventricular Hypertrophy in Congenital Heart Disease

  2011cites this paper
• The metabolic advantage of tumor cells

  2011cites this paper
• Glucose metabolism and cardiac hypertrophy.

  2011cites this paper
• [Mitochondrial dynamics: a potential new therapeutic target for heart failure].

  2011cites this paper
• Placental stem cells pre-treated with a hyaluronan mixed ester of butyric and retinoic acid to cure infarcted pig hearts: a multimodal study.

  2011cites this paper
• Enhanced glucose uptake via GLUT4 fuels recovery from calcium overload after ischaemia-reperfusion injury in sevoflurane- but not propofol-treated hearts.

  2011cites this paper
• Modulating fatty acid oxidation in heart failure.

  2011cites this paper
• Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure.

  2011cites this paper
• Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.

  2011cites this paper
• On the metabolic origin of cancer: substances that target tumor metabolism

  2011cites this paper
• Myocardial energy metabolism in

  2011cites this paper
• This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon.

  2011cites this paper
• [Mitochondrial dynamics: a potential new therapeutic target for heart failure].

  2011cites this paper
• Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure

  2010cites this paper
• Cardiac energetics in the isolated heart by NMR spectroscopy and mathematical modeling.

  2010cites this paper
• The effect of CPT-1 inhibition on myocardial function and resistance to ischemia/reperfusion injury in a rodent model of the metabolic syndrome

  2010cites this paper
• Metabolismo energético del corazón y sus proyecciones en el tratamiento de la insuficiencia cardíaca

  2010cites this paper
• [Heart energy metabolism and its role in the treatment of heart failure].

  2010cites this paper
• Bioenergetics and Metabolic Changes in the Failing Heart

  2010cites this paper
• Treatment of Heart Failure by a Methanocarba Derivative of Adenosine Monophosphate : Implication for a Role of Cardiac Purinergic P 2 X Receptors

  2010cites this paper
• Comparative Therapeutic Effi cacy of Adenocin and Non-Glycoside Cardiotonic Drugs in Chronic Heart Failure at Rest and under Conditions of Heart Overload

  2010cites this paper
• Myocardial energy metabolism in dilated cardiomyopathy

  2010cites this paper
• Myocardial fatty acid metabolism in health and disease.

  2010cites this paper
• Treatment of Heart Failure by a Methanocarba Derivative of Adenosine Monophosphate: Implication for a Role of Cardiac Purinergic P2X Receptors

  2010cites this paper
• The metabolic modulators, Etomoxir and NVP-LAB121, fail to reverse pressure overload induced heart failure in vivo

  2009cites this paper
• Metabolic remodelling of the failing heart: beneficial or detrimental?

  2009cites this paper
• Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization?

  2009cites this paper
• Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.

  2009cites this paper
• Metabolic modulation and cellular therapy of cardiac dysfunction and failure

  2009cites this paper
• Severe mechanical dyssynchrony causes regional hibernation-like changes in pigs with nonischemic heart failure.

  2009cites this paper
• Energizing diastole.

  2008cites this paper
• The Role of Mitochondrial Thioesterase-I, Uncoupling Protein-3, and CD36 in Cardiac Mitochondria

  2008cites this paper
• The malonyl CoA axis as a potential target for treating ischaemic heart disease.

  2008cites this paper
• Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure.

  2008cites this paper
• Low-carbohydrate/high-fat diet attenuates pressure overload-induced ventricular remodeling and dysfunction.

  2008cites this paper
• Impaired energetics in heart failure - a new therapeutic target.

  2008cites this paper
• Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling.

  2008cites this paper
• Metabolic remodelling of the failing heart: beneficial or detrimental?

  2008cites this paper